SCHEMBL723532

SCHEMBL723532

COC(=O)c1cc(-c2ccnc3cc(-c4cc(OC)c(OC)c(OC)c4)oc23)cc(C(F)(F)F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4C Q08493 3/20 0.40
GAK O14976 3/20 0.39
RIPK2 O43353 2/20 0.39
NLK Q9UBE8 2/20 0.39
EPHB6 O15197 1/20 0.39
ABL1 P00519 1/20 0.39
LCK P06239 1/20 0.39
EPHA1 P21709 1/20 0.39
EPHA8 P29322 1/20 0.39
TXK P42681 1/20 0.39
COQ8A Q8NI60 1/20 0.39
BRD4 O60885 4/20 0.39
NOTUM Q6P988 1/20 0.38
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
STK16 O75716 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL724038 0.92 PDE4C (0.41) PDE4CGAKRIPK2NLKEPHB6
SCHEMBL723670 0.88 PDE4C (0.41) PDE4CABL1BRD4ALDH1A1KDM4E
SCHEMBL721628 0.87 PDE4C (0.42) PDE4CBRD4ALDH1A1CYP3A4CYP1A2
SCHEMBL721518 0.85 PDE4C (0.43) PDE4CBRD4ALDH1A1CYP3A4CYP1A2
SCHEMBL724085 0.84 PDE4C (0.45) PDE4CBRD4HPGDSMN1; SMN2HSD17B10
SCHEMBL724951 0.84 PDE4C (0.42) PDE4CBRD4ALDH1A1KDM4EHPGD
SCHEMBL722295 0.83 HDAC4 (0.39) PDE4CBRD4
SCHEMBL724824 0.81 PDE4C (0.41) PDE4CBRD4ALDH1A1TUBB4ATUBB
SCHEMBL722941 0.81 CYP1A1 (0.40) PDE4CBRD4ALDH1A1CYP3A4CYP1A2
SCHEMBL723093 0.81 PDE4C (0.55) PDE4CBRD4ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP claimed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US claimed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US claimed
EP-2609100-A2 FUROPYRIDINE DERIVATIVES Merck Patent GmbH (DE) 2013-07-03 EP claimed
CN-103052640-A Furopyridine derivatives MERCK PATENT GMBH 2013-04-17 CN claimed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO claimed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225569-A1 FUROPYRIDINE DERIVATIVES SYK, FCGRT, SSB PDE4C 2858/4885GAK 3176/4885RIPK2 288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.